Bertozzi; Fabio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bertozzi; Fabio.The latest application filed is for "compounds and compositions for the treatment of cystic fibrosis".

Company Profile

9.7.12

Bertozzi; Fabio - Genova IT
Bertozzi; Fabio - Genoa IT
Bertozzi, Fabio - Kobenhavn N DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds And Compositions For The Treatment Of Cystic Fibrosis App 20220089584 - Bandiera; Tiziano ; et al.	2022-03-24
Compounds And Compositions For The Treatment Of Cystic Fibrosis App 20210292324 - Bandiera; Tiziano ; et al.	2021-09-23
Compounds and compositions for the treatment of cystic fibrosis Grant 10,968,225 - Bandiera , et al. April 6, 2	2021-04-06
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions Grant 10,865,194 - Bertozzi , et al. December 15, 2	2020-12-15
Compounds And Compositions For The Treatment Of Cystic Fibrosis App 20200369663 - Bandiera; Tiziano ; et al.	2020-11-26
Heterocyclic derivatives for the treatment of cystic fibrosis Grant 10,745,407 - Bandiera , et al. A	2020-08-18
Pyrazole Derivatives For The Treatment Of Cystic Fibrosis App 20200131157 - Bandiera; Tiziano ; et al.	2020-04-30
Heterocyclic Derivatives For The Treatment Of Cystic Fibrosis App 20200002348 - Bandiera; Tiziano ; et al.	2020-01-02
Modulation of N-acylethanolamine-hydrolysing acid amidase (NAAA) for disease treatment Grant 10,364,242 - Bertozzi , et al.	2019-07-30
Modulation Of N-acylethanolamine-hydrolysing Acid Amidase (naaa) For Disease Treatment App 20190135802 - BERTOZZI; Fabio ; et al.	2019-05-09
Therapeutically Active Bicyclic-sulphonamides And Pharmaceutical Compositions App 20190135778 - BERTOZZI; Fabio ; et al.	2019-05-09
Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors Grant 9,908,848 - Piomelli , et al. March 6, 2	2018-03-06
Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors Grant 9,828,338 - Piomelli , et al. November 28, 2	2017-11-28
Disubstituted Beta-lactones As Inhibitors Of N-acylethanolamine Acid Amidase (naaa) App 20160235707 - Piomelli; Daniele ; et al.	2016-08-18
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA) Grant 9,353,075 - Piomelli , et al. May 31, 2	2016-05-31
Carbamate Derivatives Of Lactam Based N-acylethanolamine Acid Amidase (naaa) Inhibitors App 20160068482 - Piomelli; Daniele ; et al.	2016-03-10
Amide Derivatives Of Lactam Based N-acylethanolamine Acid Amidase (naaa) Inhibitors App 20160068483 - Piomelli; Daniele ; et al.	2016-03-10
Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA) App 20130281490 - Piomelli; Daniele ; et al.	2013-10-24
Treating neuropathic pain with neuropeptide FF receptor 2 agonists App 20050136444 - Scully, Audra L. ; et al.	2005-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.